Fmoc-L-lysine is a protected amino acid derivative commonly used in solid-phase peptide synthesis. Its Fmoc (9-fluorenylmethyloxycarbonyl) group protects the alpha-amino group, while the lysine side chain remains available for selective deprotection, enabling the stepwise construction of peptides.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 105047-45-8
Nalpha-Fmoc-L-lysine hydrochloride
pharmaceutical intermediate
Benzyl (2S)-6-amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoate;hydrochloride
pharmaceutical intermediate
N-fmoc-L-norleucine
research compound
2-Cyanoethyl 2-(4-cyano-2-methoxybenzylidene)-3-oxobutanoate
pharmaceutical intermediate
2-Cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate
pharmaceutical intermediate
2-Cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate
pharmaceutical intermediate
4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid
pharmaceutical intermediate
N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-lysine hydrochloride
pharmaceutical intermediate
(2S)-6-amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid
YRKFMPDOFHQWPI-IBGZPJMESA-N
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)N[C@@H](CCCCN)C(=O)O